About this trial
This randomized controlled trial aims to compare the effects of intravenous methylprednisolone and dexamethasone on the reversal time of rocuronium by sugammadex in adult patients undergoing elective septoplasty or rhinoplasty. The primary outcome is the time from sugammadex administration to recovery of a train-of-four (TOF) ratio of 0.9. Secondary outcomes include extubation time, postoperative nausea and vomiting (PONV), pain scores, complications in the post-anesthesia care unit (PACU), and intraoperative hemodynamic parameters. The study will provide new evidence on whether perioperative corticosteroid choice modifies the efficacy of sugammadex and influences postoperative recovery.
Eligibility criteria
Qualifiers
Adult patients aged 18-65 years
American Society of Anesthesiologists (ASA) physical status I-II
Scheduled for elective septoplasty or rhinoplasty under general anesthesia
Written informed consent obtained
Disqualifiers
ASA physical status ≥ III
Emergency surgery
Known allergy or contraindication to rocuronium, sugammadex, or corticosteroids
Chronic or recent (within 3 months) systemic corticosteroid therapy
Trial design
Treatments tested in this trial
- Methylprednisolone (MP)
- Dexamethasone